Kenta Kashiwagi, Masahito Katsuki, Shin Kawamura, Senju Tachikawa, Atsuko Ono, & Akihito Koh. (2023). Fremanezumab and Non-High-Dose Galcanezumab for Comorbid Cluster Headache in Patients with Migraine: Three Cases. MDPI AG.
Chicago Style (17th ed.) CitationKenta Kashiwagi, Masahito Katsuki, Shin Kawamura, Senju Tachikawa, Atsuko Ono, and Akihito Koh. Fremanezumab and Non-High-Dose Galcanezumab for Comorbid Cluster Headache in Patients with Migraine: Three Cases. MDPI AG, 2023.
MLA (9th ed.) CitationKenta Kashiwagi, et al. Fremanezumab and Non-High-Dose Galcanezumab for Comorbid Cluster Headache in Patients with Migraine: Three Cases. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.